Abstract
We assessed Plasmodium falciparum drug resistance markers in parasites collected in 2012, 2013, and 2015 at 3 sites in Uganda. The prevalence and frequency of parasites with mutations in putative transporters previously associated with resistance to aminoquinolines, but increased sensitivity to lumefantrine (pfcrt 76T; pfmdr1 86Y and 1246Y), decreased markedly at all sites. Antifolate resistance mutations were common, with apparent emergence of mutations (pfdhfr 164L; pfdhps 581G) associated with high-level resistance. K13 mutations linked to artemisinin resistance were uncommon and did not increase over time. Changing malaria treatment practices have been accompanied by profound changes in markers of resistance.
| Original language | English |
|---|---|
| Pages (from-to) | 631-635 |
| Number of pages | 5 |
| Journal | Journal of Infectious Disease |
| Volume | 215 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 15 Feb 2017 |
| Externally published | Yes |
Keywords
- amodiaquine
- artemether
- artemisinin
- artesunate
- chloroquine
- dihydroartemisinin
- drug resistance
- K13
- lumefantrine
- Malaria
- pfcrt
- pfmdr1
- piperaquine
- Plasmodium falciparum